Nawaf, M., Ulvmar, M., Withers, D., McConnell, F., Gaspal, F., Webb, G., … Lane, P. (2017). Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity. Journal of Immunology (Baltimore, Md. : 1950), 199(3), 974-981. https://doi.org/10.4049/jimmunol.1700088 (Original work published 2017)

Carstens, J., de Sampaio, C., Yang, D., Barua, S., Wang, H., Rao, A., … Kalluri, R. (2017). Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nature Communications, 8, 15095. https://doi.org/10.1038/ncomms15095 (Original work published 2017)

Gao, J., Ward, J., Pettaway, C., Shi, L., Subudhi, S., Vence, L., … Sharma, P. (2017). VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer. Nature Medicine, 23(5), 551-555. https://doi.org/10.1038/nm.4308

Roh, W., Chen, P., Reuben, A., Spencer, C., Prieto, P., Miller, J., … Futreal, P. (2017). Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Science Translational Medicine, 9(379). https://doi.org/10.1126/scitranslmed.aah3560 (Original work published 2017)

Zamarin, D., Holmgaard, R., Ricca, J., Plitt, T., Palese, P., Sharma, P., … Allison, J. (2017). Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Nature Communications, 8, 14340. https://doi.org/10.1038/ncomms14340 (Original work published 2017)

Haymaker, C., Kim, D., Uemura, M., Vence, L., Phillip, A., McQuail, N., … Diab, A. (2017). Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade. Cancer Immunology Research, 5(2), 100-105. https://doi.org/10.1158/2326-6066.CIR-16-0223